Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
8233 ARTÍCULOS , VIENDO DEL 2431 AL 2445
Melatonin and Sleep Disturbances in Alzheimer's Disease
Prodhan AHMSU, Cavestro C, Kamal MA, Islam MA.
CNS Neurol Disord Drug Targets. 2021;20(8):736-754. doi: 10.2174/1871527320666210804155617.
Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols
Zhang M, Hu G, Shao N, Qin Y, Chen Q, Wang Y, Zhou P, Cai B.
Inflammopharmacology. 2021 Oct;29(5):1317-1329. doi: 10.1007/s10787-021-00861-4. Epub 2021 Aug 4.
Recent Progress Towards Vaccines and Antibody-based Therapies Against Alzheimer's Disease
Ji W, Gong B, Jin H, Chen X, Li P, Cheng W, Zhao Y, He B, Zhuang J, Gao J, Yin Y.
Mini Rev Med Chem. 2021;21(19):3062-3072. doi: 10.2174/1389557521666210805110920.
Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies
Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Bungau S.
Neurochem Res. 2021 Nov;46(11):2832-2851. doi: 10.1007/s11064-021-03415-w. Epub 2021 Aug 6.
Novel Therapeutic Approaches for Alzheimer's Disease: An Updated Review
Yu TW, Lane HY, Lin CH.
Int J Mol Sci. 2021 Jul 30;22(15):8208. doi: 10.3390/ijms22158208.
The Ultrastructure of Tissue Damage by Amyloid Fibrils
Koike H, Katsuno M.
Molecules. 2021 Jul 29;26(15):4611. doi: 10.3390/molecules26154611.
Cellular senescence at the crossroads of inflammation and Alzheimer's disease
Guerrero A, De Strooper B, Arancibia-Cárcamo IL.
Trends Neurosci. 2021 Sep;44(9):714-727. doi: 10.1016/j.tins.2021.06.007. Epub 2021 Aug 5.
Mukhopadhyay S, Banerjee D.
J Alzheimers Dis. 2021;83(4):1537-1552. doi: 10.3233/JAD-215065.
G N S HS, Marise VLP, Satish KS, Yergolkar AV, Krishnamurthy M, Ganesan Rajalekshmi S, Radhika K, Burri RR.
Ageing Res Rev. 2021 Nov;71:101421. doi: 10.1016/j.arr.2021.101421. Epub 2021 Aug 8.
Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research
Bi FC, Yang XH, Cheng XY, Deng WB, Guo XL, Yang H, Wang Y, Li J, Yao Y.
Transl Neurodegener. 2021 Aug 9;10(1):27. doi: 10.1186/s40035-021-00252-3.
Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Implications by Natural Products
Rather MA, Khan A, Alshahrani S, Rashid H, Qadri M, Rashid S, Alsaffar RM, Kamal MA, Rehman MU.
Mediators Inflamm. 2021 Jul 31;2021:9982954. doi: 10.1155/2021/9982954. eCollection 2021.
Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential
Sharma VK, Singh TG, Singh S, Garg N, Dhiman S.
Neurochem Res. 2021 Dec;46(12):3103-3122. doi: 10.1007/s11064-021-03418-7. Epub 2021 Aug 12.
Zhao H, Huang X, Tong Z.
ChemMedChem. 2021 Nov 19;16(22):3376-3390. doi: 10.1002/cmdc.202100428. Epub 2021 Sep 8.
The Structure Biology of Tau and Clue for Aggregation Inhibitor Design
Wang D, Huang X, Yan L, Zhou L, Yan C, Wu J, Su Z, Huang Y.
Protein J. 2021 Oct;40(5):656-668. doi: 10.1007/s10930-021-10017-6. Epub 2021 Aug 17.
Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease
Apátiga-Pérez R, Soto-Rojas LO, Campa-Córdoba BB, Luna-Viramontes NI, Cuevas E, Villanueva-Fierro I, Ontiveros-Torres MA, Bravo-Muñoz M, Flores-Rodríguez P, Garcés-Ramirez L, de la Cruz F, Montiel-Sosa JF, Pacheco-Herrero M, Luna-Muñoz J.
Metab Brain Dis. 2022 Jan;37(1):39-50. doi: 10.1007/s11011-021-00814-4. Epub 2021 Aug 18.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.